⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Letter AI Raises $40M Series B to Bring Deal-Level Intelligence to Revenue Enablement
prnewswire.com
ADBE
NVO
ZIP
CRM
HUBS
Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access
prnewswire.com
NVO
Novo Nordisk: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China
globenewswire.com
NVO
Novo Nordisk A/S Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – NVO
businesswire.com
NVO
Novo Nordisk A/S (NVO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NVO
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-label head-to-head REDEFINE 4 trial in people with obesity, the primary endpoint was not achieved
globenewswire.com
NVO
Novo Nordisk’s Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity
globenewswire.com
NVO
LLY
Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S
globenewswire.com
NVO
Philanthropic Partnership Backs Country-Led Research to Guide the Use of AI in Health
prnewswire.com
NVO